Reported Earnings • May 14
First quarter 2026 earnings released First quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025). Ankündigung • Apr 06
Polisan Holding A.S., Annual General Meeting, Apr 30, 2026 Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey New Risk • Apr 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change). Board Change • Apr 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 12
Full year 2025 earnings released Full year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024). Reported Earnings • Nov 12
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance. New Risk • Sep 16
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. New Risk • Jun 24
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m). Reported Earnings • May 14
First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024) First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings. New Risk • Apr 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change). Ankündigung • Mar 27
Polisan Holding A.S., Annual General Meeting, Apr 28, 2025 Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey Reported Earnings • Mar 09
Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023) Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years. Reported Earnings • Nov 10
Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023) Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Sep 23
Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD) Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD) Reported Earnings • Sep 06
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Aug 22
Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024 Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024 Reported Earnings • Jun 05
First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023) First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • May 22
Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024 Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024 Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Apr 02
Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022) Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years. Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years. New Risk • Nov 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change). Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years. Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022) Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 20
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years. Reported Earnings • Aug 06
Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022) Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years. Reported Earnings • May 07
First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022) First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 03
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years. Upcoming Dividend • Mar 29
Upcoming dividend of ₺0.40 per share at 3.4% yield Eligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%). Reported Earnings • Mar 03
Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021) Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years. Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years. Reported Earnings • Nov 02
Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021) Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 27
Investor sentiment improved over the past week After last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years. Valuation Update With 7 Day Price Move • Oct 04
Investor sentiment improved over the past week After last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improved over the past week After last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years. Reported Earnings • Aug 10
Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021) Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improved over the past week After last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years. Valuation Update With 7 Day Price Move • May 24
Investor sentiment improved over the past week After last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years. Valuation Update With 7 Day Price Move • May 04
Investor sentiment improved over the past week After last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021) First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Apr 05
Upcoming dividend of ₺0.02 per share Eligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%). Upcoming Dividend • Mar 30
Upcoming dividend of ₺0.02 per share Eligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%). Reported Earnings • Mar 09
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 05
Third quarter 2021 earnings released The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 13
Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • Mar 30
Upcoming dividend of ₺0.013 per share Eligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%). Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years. Reported Earnings • Mar 12
Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year. Is New 90 Day High Low • Feb 24
New 90-day low: ₺3.65 The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period. Is New 90 Day High Low • Jan 25
New 90-day high: ₺4.32 The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period. Reported Earnings • Nov 01
Third quarter earnings released Over the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year. Is New 90 Day High Low • Oct 05
New 90-day high: ₺3.38 The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.